Azidothymidine resistance of H9 human T-cell lymphoma cells is associated with decreased sensitivity to antitumor agents and inhibition of apoptosis.

MLA

Cinatl, J., Jr, et al. “Azidothymidine Resistance of H9 Human T-Cell Lymphoma Cells Is Associated with Decreased Sensitivity to Antitumor Agents and Inhibition of Apoptosis.” International Journal of Molecular Medicine, vol. 2, no. 6, Dec. 1998, pp. 685–91. EBSCOhost, https://doi.org/10.3892/ijmm.2.6.685.

APA

Cinatl, J., Jr, Kotchetkov, R., Gröschel, B., Cinatl, J., Driever, P. H., Kabickova, H., Kornhuber, B., Schwabe, D., & Doerr, H. W. (1998). Azidothymidine resistance of H9 human T-cell lymphoma cells is associated with decreased sensitivity to antitumor agents and inhibition of apoptosis. International Journal of Molecular Medicine, 2(6), 685–691. https://doi.org/10.3892/ijmm.2.6.685

Chicago

Cinatl, J, Jr, R Kotchetkov, B Gröschel, J Cinatl, P H Driever, H Kabickova, B Kornhuber, D Schwabe, and H W Doerr. 1998. “Azidothymidine Resistance of H9 Human T-Cell Lymphoma Cells Is Associated with Decreased Sensitivity to Antitumor Agents and Inhibition of Apoptosis.” International Journal of Molecular Medicine 2 (6): 685–91. doi:10.3892/ijmm.2.6.685.